Adalimumab (Humira) Prefilled Syringe from China
Adalimumab is a fully human monoclonal antibody inhibiting TNF-alpha, for rheumatoid arthritis and Crohn's disease. It qualifies for HTS 3002.15.00.11 as a measured-dose immunological product for retail sale, regulating immune processes per chapter notes.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Secure prior FDA notice and biologics import license; validate TNF-targeting mechanism in docs
• Use insulated packaging with temperature monitors; declare exact measured doses per syringe